Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marcel Waelchli"'
Autor:
Eva Herzog, Sabrina Schenk, Marcel Waelchli, Samuel D. Wright, Paolo Zanoni, Ingo Pragst, Svetlana Diditchenko, Andreas Seubert, Marina Cuchel, Daniel J. Rader, Jochen Mueller-Cohrs, Andreas Gille
Publikováno v:
Journal of Applied Toxicology. 36:1038-1047
Human apolipoprotein A-I preparations reconstituted with phospholipids (reconstituted high-density lipoprotein [HDL]) have been used in a large number of animal and human studies to investigate the physiological role of apolipoprotein A-I. Several of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4c3a09b5ea7e4a457503603e78cd98a
https://doi.org/10.1002/jat.3264
https://doi.org/10.1002/jat.3264
Autor:
Eva, Herzog, Ingo, Pragst, Marcel, Waelchli, Andreas, Gille, Sabrina, Schenk, Jochen, Mueller-Cohrs, Svetlana, Diditchenko, Paolo, Zanoni, Marina, Cuchel, Andreas, Seubert, Daniel J, Rader, Samuel D, Wright
Publikováno v:
Journal of applied toxicology : JAT. 36(8)
Human apolipoprotein A-I preparations reconstituted with phospholipids (reconstituted high-density lipoprotein [HDL]) have been used in a large number of animal and human studies to investigate the physiological role of apolipoprotein A-I. Several of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2e3c001866237f6f8ac06a1d26e8b38
https://pubmed.ncbi.nlm.nih.gov/26651060
https://pubmed.ncbi.nlm.nih.gov/26651060
Autor:
Andrew Leis, Samuel D. Wright, Andreas Gille, Ross Hamilton, Ingo Pragst, Svetlana Diditchenko, Marcel Waelchli, Dominik Stadler
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 33(9)
Objective— The ability of high-density lipoprotein (HDL) to remove cholesterol from atherosclerotic plaque is thought to underlie its inverse correlation with cardiovascular risk. Our objective was to produce and characterize a human apolipoprotein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac35864a55692ea78dbb5c14ec784bee
https://pubmed.ncbi.nlm.nih.gov/23868939
https://pubmed.ncbi.nlm.nih.gov/23868939
Autor:
Rachael Easton, Svetlana Diditchenko, Martin Spycher, Marcel Waelchli, Martin Imboden, Sabrina Schenk, Ingo Pragst, Samuel D. Wright, CSL Behring AG
Publikováno v:
Journal of the American College of Cardiology. (13):E491
The efflux of cellular cholesterol mediated by apoA-I and ATP-binding cassette transporter A1 (ABCA1) is thought to underlie many of the cardiovascular benefits of HDL. Several groups have manufactured apoA-I preparations with the aim of making an in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd76764a13a5d84a52f0505a468603a0